1 Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, USA.
2 Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
Otolaryngol Head Neck Surg. 2018 Feb;158(2):386-390. doi: 10.1177/0194599817728920. Epub 2017 Sep 5.
Objective Comorbid asthma is associated with decreased quality of life (QOL) in chronic rhinosinusitis (CRS). It is unclear whether this association is independent of the patients' clinical asthma status. We therefore sought to determine if asthma is associated with lower QOL in CRS, independent of asthma control. Study Design Cross-sectional cohort study of 350 patients with CRS. Setting Tertiary academic rhinology clinic. Subjects and Methods In total, 350 participants with CRS were recruited and 28.3% were asthmatic. CRS-specific QOL was measured using the 22-item Sinonasal Outcome Test (SNOT-22). Asthma control was assessed with the Asthma Control Test (ACT). General health-related QOL was assessed with the EuroQoL 5-dimensional general health-related quality of life survey visual analog scale (EQ-5D VAS). Associations were sought between SNOT-22 and EQ-5D VAS (dependent variables) and asthma (independent variable), while controlling for ACT. ACT score for patients with CRS without asthma was set at 25 (indicating completely controlled, asymptomatic asthma). Results Comorbid asthma was associated with SNOT-22 (β = 11.8; 95% confidence interval [CI], 6.2-17.3; P < .001) and EQ-5D VAS (β = -6.2; 95% CI, -11.2 to -1.3; P = .014). After controlling for ACT, asthma was no longer associated with SNOT-22 ( P = .147) or EQ-5D VAS ( P = .994). Instead, ACT score was associated with SNOT-22 (β = -2.1; 95% CI, -3.2 to -1.1; P < .001) and EQ-5D VAS (β = 2.1; 95% CI, 1.1 to 3.0; P < .001). ACT score completely drove the association between asthma and worse QOL. Conclusion Comorbid asthma is not necessarily reflective of decreased QOL in CRS. The association of comorbid asthma with lower QOL in CRS is related to the clinical status (eg, control) of asthma.
合并哮喘会降低慢性鼻-鼻窦炎(CRS)患者的生活质量(QOL)。目前尚不清楚这种关联是否独立于患者的临床哮喘状况。因此,我们旨在确定哮喘是否与 CRS 患者的 QOL 降低有关,而与哮喘控制无关。
对 350 例 CRS 患者进行横断面队列研究。
三级学术鼻科诊所。
共招募了 350 名 CRS 患者,其中 28.3%患有哮喘。使用 22 项鼻-鼻窦结局测试(SNOT-22)来衡量 CRS 特异性 QOL。使用哮喘控制测试(ACT)评估哮喘控制。使用 EuroQoL 五维健康相关生活质量调查视觉模拟量表(EQ-5D VAS)评估一般健康相关 QOL。在控制 ACT 的情况下,研究人员寻求 SNOT-22 和 EQ-5D VAS(因变量)与哮喘(自变量)之间的相关性。对于无哮喘的 CRS 患者,将 ACT 评分设定为 25(表示完全控制、无症状的哮喘)。
合并哮喘与 SNOT-22(β=11.8;95%置信区间[CI],6.2-17.3;P<0.001)和 EQ-5D VAS(β=-6.2;95%CI,-11.2 至-1.3;P=0.014)相关。在控制 ACT 后,哮喘与 SNOT-22(P=0.147)或 EQ-5D VAS(P=0.994)不再相关。相反,ACT 评分与 SNOT-22(β=-2.1;95%CI,-3.2 至-1.1;P<0.001)和 EQ-5D VAS(β=2.1;95%CI,1.1 至 3.0;P<0.001)相关。ACT 评分完全驱动了哮喘与更差的 QOL 之间的关联。
合并哮喘不一定反映 CRS 患者的 QOL 降低。合并哮喘与 CRS 患者 QOL 降低之间的关联与哮喘的临床状况(如控制情况)有关。